IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors	PDAC; Solid Tumor Cancer	Recruiting	Phase 1 / Phase 2	2026-02-27		NCT07441174

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
InxMed (Shanghai) Co., Ltd.	10
InxMed (Shenzhen) Co.,Ltd.	1
Ranok Therapuetics Co. Ltd.	2

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Drum Tower Hospital, Medical School of Nanjing University	Nanjing	China	6
Cancer Hospital Chinese Academy of Medical Sciences	Beijing	China	29
Fujian Cancer Hospital	Fuzhou	China	55
Hunan Cancer Hospital	Changsha	China	87
Jiangsu Province Hospital	Nanjing	China	37
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine	Shanghai	China	4
Shandong Cancer Hospital	Jinan	China	31
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	34
The First Affiliated Hospital of China Medical University	Shengyang	China	1
The First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	1
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	41
The First Affiliated Hospital of Xi'an Jiaotong University	Xi’an	China	22
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310005	Hangzhou	China	1